Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial

• Roger Owen,
• John Jones,
• David Meads,
• David A Cairns,
• Christopher Parrish,
• Gordon Cook,
• Neil Rabin,
• Matthew Jenner,
• Martin Kaiser,
• Kevin Boyd,
• Graham Jackson,
• Catherine Olivier,
• Amy Beth Coulson,
• Kara-Louise Royle,
• Charlotte Pawlyn,
• Anna Hockaday,
• Jennifer Bird,
• Stella Bowcock,
• Ruth de Tute,
• Hayley Gardner,
• Bryony Dawkins,
• Rowena Henderson,
• Phillip Best,
• Bhuvan Kishore,
• Mark Drayson

Affiliations

Roger Owen

2 Department of Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK

John Jones

King`s College Hospital, London, UK

David Meads

Leeds Institute of Health Sciences, University of Leeds, Leeds, UK

David A Cairns

1 Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, West Yorkshire, UK

Christopher Parrish

Department of Haematology, St James`s University Hospital, Leeds, UK

Gordon Cook

Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK

Neil Rabin

5 Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK

Matthew Jenner

Department of Haematology, Southampton General Hospital, Southampton, UK

Martin Kaiser

Centre for Myeloma Research, Institute of Cancer Research, London, UK

Kevin Boyd

3Fédération Internationale de Natation (FINA) Sports Medicine Committee, Lausanne, Switzerland

Graham Jackson

head of branch (retired)

Catherine Olivier

6 Département de médecine sociale et préventive, École de santé publique, Université de Montréal, Montréal, Québec, Canada

Amy Beth Coulson

Leeds Institute of Clinical Trials Research, University of Leeds Clinical Trials Research Unit, Leeds, West Yorkshire, UK

Kara-Louise Royle

Leeds Institute of Clinical Trials Research, University of Leeds Clinical Trials Research Unit, Leeds, West Yorkshire, UK

Charlotte Pawlyn

Cancer Research UK London Research Institute, London, UK

Anna Hockaday

Leeds Institute of Clinical Trials Research, University of Leeds Clinical Trials Research Unit, Leeds, West Yorkshire, UK

Jennifer Bird

Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK

Stella Bowcock

Department of Haematology, Kings College Hospital NHS Foundation Trust, Princess Royal Hospital, Hull, UK

Ruth de Tute

Haematology Malignancy Diagnostic Service (HMDS), St James`s University Hospital, Leeds, West Yorkshire, UK

Hayley Gardner

Department of Haematology and Stem Cell Transplantation, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Bryony Dawkins

Academic Unit of Health Economics, University of Leeds, Leeds Institute of Health Sciences, Leeds, West Yorkshire, UK

Rowena Henderson

Leeds Institute of Clinical Trials Research, University of Leeds Clinical Trials Research Unit, Leeds, West Yorkshire, UK

Phillip Best

Leeds Institute of Clinical Trials Research, University of Leeds Clinical Trials Research Unit, Leeds, West Yorkshire, UK

Bhuvan Kishore

Department of Haematology and Stem Cell Transplantation, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK

Mark Drayson

Institute of Immunology and Immunotherapy, Department of Haematology, University of Birmingham, Birmingham, UK